Crédit Industriel et Commercial’s Pfizer PFE Stock Holding History

Crédit Industriel et Commercial’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.34M	Buy	138,500 +4,500	+3%	+$118K	0.21%	99
2026 Q1	$3.76M	Buy	134,000 +9,000	+7%	+$240K	0.29%	94
2025 Q4	$3.11M	Buy	125,000 +12,500	+11%	+$315K	0.24%	104
2025 Q3	$2.87M	Buy	112,500 +100,000	+800%	+$2.47M	0.24%	101
2025 Q2	$303K	Buy	12,500 +2,500	+25%	+$58.3K	0.03%	313
2025 Q1	$253K	Buy	10,000 +3,000	+43%	+$78.5K	0.03%	306
2024 Q4	$186K	Buy	+7,000	New	+$190K	0.02%	257

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Crédit Industriel et Commercial's PFE Position: Q2 2026 in Review

Crédit Industriel et Commercial increased its Pfizer (PFE) stake by 87% in Q2 2026, buying an estimated $415K and bringing the position to 34,071 shares worth $820K. The position accounts for 0.05% of the portfolio, ranked #218.

Crédit Industriel et Commercial first reported a position in PFE in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.15M in Q3 2025. 1,944 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Crédit Industriel et Commercial held 34,071 shares of Pfizer worth $820K as of Q2 2026.
Crédit Industriel et Commercial bought 15,866 Pfizer shares in Q2 2026, an estimated $415K.
Pfizer made up 0.05% of Crédit Industriel et Commercial's portfolio in Q2 2026, its #218 holding.
Crédit Industriel et Commercial first reported a position in Pfizer in Q3 2025 and has held it in 4 quarters since.
Crédit Industriel et Commercial's Pfizer position peaked at $1.15M in Q3 2025.
1,944 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Crédit Industriel et Commercial's 13F filing for Q2 2026, filed 24 Jul 2026.